Literature DB >> 35224994

High-calorie diet results in reversible obesity-related glomerulopathy in adult zebrafish regardless of dietary fat.

Evan M Zeitler1, J Charles Jennette1,2, Jennifer E Flythe1, Ronald J Falk1, John S Poulton1.   

Abstract

Obesity is a risk factor for the development of kidney disease. The role of diet in this association remains undetermined, in part due to practical limitations in studying nutrition in humans. In particular, the relative importance of calorie excess versus dietary macronutrient content is poorly understood. For example, it is unknown if calorie restriction modulates obesity-related kidney pathology. To study the effects of diet-induced obesity in a novel animal model, we treated zebrafish for 8 wk with diets varied in both calorie and fat content. Kidneys were evaluated by light and electron microscopy. We evaluated glomerular filtration barrier function using a dextran permeability assay. We assessed the effect of diet on podocyte sensitivity to injury using an inducible podocyte injury model. We then tested the effect of calorie restriction on the defects caused by diet-induced obesity. Fish fed a high-calorie diet developed glomerulomegaly (mean: 1,211 vs. 1,010 µm2 in controls, P = 0.007), lower podocyte density, foot process effacement, glomerular basement membrane thickening, tubular enlargement (mean: 1,038 vs. 717 µm2 in controls, P < 0.0001), and ectopic lipid deposition. Glomerular filtration barrier dysfunction and increased susceptibility to podocyte injury were observed with high-calorie feeding regardless of dietary fat content. These pathological changes resolved with 4 wk of calorie restriction. Our findings suggest that calorie excess rather than dietary fat drives obesity-related kidney dysfunction and that inadequate podocyte proliferation in response to glomerular enlargement may cause podocyte dysfunction. We also demonstrate the value of zebrafish as a novel model for studying diet in obesity-related kidney disease.NEW & NOTEWORTHY Obesity is a risk factor for kidney disease. The role of diet in this association is difficult to study in humans. In this study, zebrafish fed a high-calorie diet, regardless of fat macronutrient composition, developed glomerulomegaly, foot process effacement, and filtration barrier dysfunction, recapitulating the changes seen in humans with obesity. Calorie restriction reversed the changes. This work suggests that macronutrient composition may be less important than total calories in the development of obesity-related kidney disease.

Entities:  

Keywords:  calorie restriction; diet; obesity; obesity-related glomerulopathy; zebrafish

Mesh:

Substances:

Year:  2022        PMID: 35224994      PMCID: PMC8977181          DOI: 10.1152/ajprenal.00018.2022

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  65 in total

1.  Deficiency of a transmembrane prolyl 4-hydroxylase in the zebrafish leads to basement membrane defects and compromised kidney function.

Authors:  Jaana Hyvärinen; Mataleena Parikka; Raija Sormunen; Mika Rämet; Karl Tryggvason; Kari I Kivirikko; Johanna Myllyharju; Peppi Koivunen
Journal:  J Biol Chem       Date:  2010-10-15       Impact factor: 5.157

2.  BMI is associated with the development of chronic kidney diseases in hypertensive patients with normal renal function.

Authors:  Liling Xie; Binyan Wang; Chongfei Jiang; Xianglin Zhang; Yun Song; Youbao Li; Jiancheng Wang; Yaren Yu; Min Liang; Guobao Wang; Yan Zhang; Jianping Li; Yong Huo; Xiping Xu; Jing Nie; Xianhui Qin
Journal:  J Hypertens       Date:  2018-10       Impact factor: 4.844

Review 3.  Little fish, big catch: zebrafish as a model for kidney disease.

Authors:  Shahram Jevin Poureetezadi; Rebecca A Wingert
Journal:  Kidney Int       Date:  2016-04-16       Impact factor: 10.612

4.  Podocyte lesions in patients with obesity-related glomerulopathy.

Authors:  Hui-Mei Chen; Zhi-Hong Liu; Cai-Hong Zeng; Shi-Jun Li; Qing-Wen Wang; Lei-Shi Li
Journal:  Am J Kidney Dis       Date:  2006-11       Impact factor: 8.860

5.  Smad3 deficiency protects mice from obesity-induced podocyte injury that precedes insulin resistance.

Authors:  Yu B Y Sun; Xinli Qu; Victor Howard; Lie Dai; Xiaoyun Jiang; Yi Ren; Ping Fu; Victor G Puelles; David J Nikolic-Paterson; Georgina Caruana; John F Bertram; Mark W Sleeman; Jinhua Li
Journal:  Kidney Int       Date:  2015-05-06       Impact factor: 10.612

6.  Medaka fish, Oryzias latipes, as a model for human obesity-related glomerulopathy.

Authors:  Koichiro Ichimura; Yusuke Kawashima; Tomomi Nakamura; Rebecca Powell; Yuya Hidoh; Shuji Terai; Isao Sakaida; Yoshio Kodera; Takashi Tsuji; Jian-Xing Ma; Tatsuo Sakai; Hiroyuki Matsumoto; Tomoko Obara
Journal:  Biochem Biophys Res Commun       Date:  2013-01-23       Impact factor: 3.575

7.  Pathological influence of obesity on renal structural changes in chronic kidney disease.

Authors:  Shigeko Kato; Arifa Nazneen; Yumiko Nakashima; Mohammed S Razzaque; Tomoya Nishino; Akira Furusu; Noriaki Yorioka; Takashi Taguchi
Journal:  Clin Exp Nephrol       Date:  2009-04-29       Impact factor: 2.801

8.  Proximal tubular hypertrophy and enlarged glomerular and proximal tubular urinary space in obese subjects with proteinuria.

Authors:  Ana Tobar; Yaacov Ori; Sydney Benchetrit; Gai Milo; Michal Herman-Edelstein; Boris Zingerman; Netta Lev; Uzi Gafter; Avry Chagnac
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

9.  Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial.

Authors:  Amir Tirosh; Rachel Golan; Ilana Harman-Boehm; Yaakov Henkin; Dan Schwarzfuchs; Assaf Rudich; Julia Kovsan; Georg M Fiedler; Matthias Blüher; Michael Stumvoll; Joachim Thiery; Meir J Stampfer; Iris Shai
Journal:  Diabetes Care       Date:  2013-05-20       Impact factor: 19.112

10.  High-fat diet promotes renal injury by inducing oxidative stress and mitochondrial dysfunction.

Authors:  Yue Sun; Xin Ge; Xue Li; Jinrong He; Xinzhi Wei; Jie Du; Jian Sun; Xin Li; Zhe Xun; Weicheng Liu; Hao Zhang; Zhan-You Wang; Yan Chun Li
Journal:  Cell Death Dis       Date:  2020-10-24       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.